BioLargo, Inc. (BLGO)
OTCMKTS · Delayed Price · Currency is USD
0.2080
-0.0007 (-0.34%)
Jun 4, 2025, 3:59 PM EDT

BioLargo Statistics

Total Valuation

BioLargo has a market cap or net worth of 63.15 million. The enterprise value is 61.12 million.

Market Cap 63.15M
Enterprise Value 61.12M

Important Dates

The last earnings date was Wednesday, May 14, 2025.

Earnings Date May 14, 2025
Ex-Dividend Date n/a

Share Statistics

BioLargo has 303.61 million shares outstanding. The number of shares has increased by 3.63% in one year.

Current Share Class 303.61M
Shares Outstanding 303.61M
Shares Change (YoY) +3.63%
Shares Change (QoQ) +0.02%
Owned by Insiders (%) 6.13%
Owned by Institutions (%) 0.04%
Float 261.33M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 3.88
PB Ratio 12.41
P/TBV Ratio 8.30
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -19.42
EV / Sales 3.75
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -10.38

Financial Position

The company has a current ratio of 2.14, with a Debt / Equity ratio of 0.60.

Current Ratio 2.14
Quick Ratio 2.01
Debt / Equity 0.60
Debt / EBITDA n/a
Debt / FCF -0.52
Interest Coverage -63.14

Financial Efficiency

Return on equity (ROE) is -107.31% and return on invested capital (ROIC) is -45.36%.

Return on Equity (ROE) -107.31%
Return on Assets (ROA) -33.38%
Return on Invested Capital (ROIC) -45.36%
Return on Capital Employed (ROCE) -76.07%
Revenue Per Employee 387,810
Profits Per Employee -74,929
Employee Count 44
Asset Turnover 1.60
Inventory Turnover 29.65

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -24.36% in the last 52 weeks. The beta is 0.19, so BioLargo's price volatility has been lower than the market average.

Beta (5Y) 0.19
52-Week Price Change -24.36%
50-Day Moving Average 0.24
200-Day Moving Average 0.24
Relative Strength Index (RSI) 42.65
Average Volume (20 Days) 394,106

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BioLargo had revenue of 16.29 million and -3.15 million in losses. Loss per share was -0.01.

Revenue 16.29M
Gross Profit 7.10M
Operating Income -5.43M
Pretax Income -5.49M
Net Income -3.15M
EBITDA -5.23M
EBIT -5.43M
Loss Per Share -0.01
Full Income Statement

Balance Sheet

The company has 2.56 million in cash and 3.05 million in debt, giving a net cash position of -489,000 or -0.00 per share.

Cash & Cash Equivalents 2.56M
Total Debt 3.05M
Net Cash -489,000
Net Cash Per Share -0.00
Equity (Book Value) 5.09M
Book Value Per Share 0.03
Working Capital 3.85M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -5.52 million and capital expenditures -372,000, giving a free cash flow of -5.89 million.

Operating Cash Flow -5.52M
Capital Expenditures -372,000
Free Cash Flow -5.89M
FCF Per Share -0.02
Full Cash Flow Statement

Margins

Gross margin is 43.56%, with operating and profit margins of -33.34% and -19.32%.

Gross Margin 43.56%
Operating Margin -33.34%
Pretax Margin -33.72%
Profit Margin -19.32%
EBITDA Margin -32.13%
EBIT Margin -33.34%
FCF Margin n/a

Dividends & Yields

BioLargo does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.63%
Shareholder Yield n/a
Earnings Yield -4.98%
FCF Yield -9.33%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a